Johnson & Johnson Financial Statements FY2021-FY2026Q3

Johnson & Johnson (JNJ) Financial Statements in Beancount — Open Ledger

Johnson & Johnson's income statement and balance sheet, FY2021 through FY2026Q3, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Part of the Open Ledger project on beancount.io.

Browse it live: beancount.io/ledger/open_ledger/johnson-johnson

Latest analysis: Johnson & Johnson Q3 2026 Earnings: $0.09 EPS on $25.4B Sales as a $5.5B Talc Charge Meets a Guidance Raise

Key Figures

Amounts in MUSD (millions of US dollars), exactly as the ledger records them.

What's Inside

Fiscal years end the Sunday nearest December 31 (52 weeks; 53 weeks in FY2020 and FY2026). All figures sourced from Johnson & Johnson Form 10-K / 10-Q filings and earnings releases. FY2021–FY2023 are presented on the restated continuing-operations basis (Innovative Medicine + MedTech); the Consumer Health business separated as Kenvue in August 2023 appears only in Expenses:DiscontinuedOperations. The filing combines retained earnings and additional paid-in capital in one caption, held here on Equity:RetainedEarnings.

Quick Start

uvx --from beancount bean-check main.bean
uvx --from beanquery bean-query main.bean \
  "SELECT year, sum(position) WHERE account ~ '^Income:Revenue' GROUP BY year ORDER BY year"

Zero output from bean-check means the ledger is internally consistent: every
income statement sums to zero and every balance-sheet snapshot reconciles to
the filed totals. The query prints revenue by calendar year; income is a
credit, so it shows as a negative number. Open main.bean in Fava
or import it into beancount.io to explore it visually.

Methodology

• Balance sheet — pad / balance directives assert each period-end
  figure against the filing named in that period file's source banner.
• Income statement — one zero-sum transaction per period: Income
  negative (credit), Expenses positive (debit), with the arithmetic check in
  a comment directly above it.
• Unit — MUSD; 25,399 MUSD means 25,399 million US dollars.
• Additional accounts — Expenses:DiscontinuedOperations, opened beyond the
  standard chart (see each account's open line in main.bean).

Analysis

• Johnson & Johnson Q3 2026 Earnings: $0.09 EPS on $25.4B Sales as a $5.5B Talc Charge Meets a Guidance Raise — FY2026Q3

Corrections

Found a figure that does not match the filing? Email
[email protected] with the period, the account
and the filing page. Corrections are committed with the source cited.

About Open Ledger

Open Ledger is a growing library of public-company financial statements
published as plain-text accounting at
beancount.io/ledger — git-versioned, diffable
across companies, and auditable against primary filings. Read the analysis
behind the numbers on the beancount.io blog.

Disclaimer

This ledger is an independent reconstruction of Johnson & Johnson's publicly filed
financial statements, provided for educational and informational purposes
only. It is not investment, financial, legal, tax, or accounting advice, and
is not an offer or recommendation to buy or sell any security. Beancount.io is
not affiliated with, endorsed by, or sponsored by Johnson & Johnson; all trademarks
belong to their respective owners. Figures may contain errors, omissions, or
simplifications and may lag the latest filings — the company's own regulatory
filings are the authoritative source. Provided "as is" without warranty of any
kind; use at your own risk.